1 4 8 2 VOLUME 22 | NUMBER 12 | DECEMBER 2016 nature medicine A major therapeutic goal for type 1 diabetes (T1D) is to induce autoantigen-specific tolerance of T cells. This could suppress autoimmunity in those at risk for the development of T1D, as well as in those with established disease who receive islet replacement or regeneration therapy. Because functional studies of human autoreactive T cell responses have been limited largely to peripheral blood-derived T cells 1-3 , it is unclear how representative the peripheral T cell repertoire is of T cells infiltrating the islets. Our knowledge of the insulitic T cell repertoire is derived from histological and immunohistochemical analyses of insulitis 4-8 , the identification of autoreactive CD8 + T cells in situ, in islets of human leukocyte antigen (HLA)-A2 + donors 9 and isolation and identification of DQ8 and DQ2-DQ8 heterodimer-restricted, proinsulin-reactive CD4 + T cells grown from islets of a single donor with T1D 10 . Here we present an analysis of 50 of a total of 236 CD4 + and CD8 + T cell lines grown from individual handpicked islets or clones directly sorted from handpicked, dispersed islets from nine donors with T1D. Seventeen of these T cell lines and clones reacted to a broad range of studied native islet antigens and to post-translationally modified peptides. These studies demonstrate the existence of a variety of islet-infiltrating, islet-autoantigen reactive T cells in individuals with T1D, and these data have implications for the design of successful immunotherapies.
A major therapeutic goal for type 1 diabetes (T1D) is to induce autoantigen-specific tolerance of T cells. This could suppress autoimmunity in those at risk for the development of T1D, as well as in those with established disease who receive islet replacement or regeneration therapy. Because functional studies of human autoreactive T cell responses have been limited largely to peripheral blood-derived T cells [1] [2] [3] , it is unclear how representative the peripheral T cell repertoire is of T cells infiltrating the islets. Our knowledge of the insulitic T cell repertoire is derived from histological and immunohistochemical analyses of insulitis [4] [5] [6] [7] [8] , the identification of autoreactive CD8 + T cells in situ, in islets of human leukocyte antigen (HLA)-A2 + donors 9 and isolation and identification of DQ8 and DQ2-DQ8 heterodimer-restricted, proinsulin-reactive CD4 + T cells grown from islets of a single donor with T1D 10 . Here we present an analysis of 50 of a total of 236 CD4 + and CD8 + T cell lines grown from individual handpicked islets or clones directly sorted from handpicked, dispersed islets from nine donors with T1D. Seventeen of these T cell lines and clones reacted to a broad range of studied native islet antigens and to post-translationally modified peptides. These studies demonstrate the existence of a variety of islet-infiltrating, islet-autoantigen reactive T cells in individuals with T1D, and these data have implications for the design of successful immunotherapies.
Information on the specificity and function of the T cell repertoire that infiltrates human islets in T1D is limited [9] [10] [11] [12] [13] [14] . Therefore, we examined the lymphocytic infiltrate from handpicked islets from nine donors with T1D (2-20 years disease duration), seven donors without T1D and two donors with type 2 diabetes (T2D). The disease history, islet cellular infiltrate detected by immunohistochemistry, insulin content, lymphocytes detected by flow cytometry and the number of T cell lines and clones grown from the islets are summarized ( Table 1 and Supplementary Table 1) . Five of nine T1D donors showed insulin-positive islets. The features of control samples (Is.1-Is.9) are shown in Supplementary Table 2. The schema of islet handling is shown in Figure 1a . To recover the maximum number of T cells from islets, two methods were used. First, T cells were sorted by flow cytometry directly from enzymatically dispersed, handpicked islets. Given that carryover of T cells in the dispersed acinar tissue can occur in handpicking, we developed a second method, a gel-based culture protocol (Online Methods) for islets to visualize T cell outgrowth directly from individual islets. We recovered both CD4 + and CD8 + T cells from nine of nine islet donors with T1D, and CD4 + T cells from one donor without T1D from the two methods combined. Representative flow cytometry profiles of isolated, handpicked islets from donor nPOD69 (with T1D) and Is.7 donor (without T1D) are shown in Figure 1b ,c. For the islets from donors with T1D, an average of 221 ± 471 CD4 + T cells and 155 ± 210 CD8 + T cells were detected (average CD4:CD8 ratio, 1.4:1). A greater frequency of CD8 + T cells (P = 0.03) was detected from the islets of donors with T1D than from those of donors without T1D ( Table 1 and Supplementary Table 1) . These results are expected as seen from immunohistochemistry studies of pancreas tissue from donors with and without T1D 5, 6 .
Cellular outgrowth from handpicked islet remnants was seen after 5-10 d with T cell stimulation and growth factors (Fig. 1d) , with outgrowth size increasing over time. We detected CD4 + T cell lines in all islet samples from donors with T1D (P = 0.003), as compared to the islets from the control donors or with T2D. From six of nine donors with T1D, T cell lines grown directly from islets contained both CD4 + and CD8 + T cells (designated 'mixed'), ranging from CD4:CD8 percentages of 85:15 to 45:55 (Supplementary Fig. 1 ), that require further sorting and analyses, given that CD4 + T cell growth bias occurs over CD8 + T cells. CD8 + T cell lines were detected by flow cytometry or grown from eight of nine donors with T1D; no CD8 + lines were grown from the islets of donors without T1D. No T cell outgrowth from islets of donors without T1D or donors with T2D was observed except for five CD4 + T cell lines from donor Is.7. These data, combined with the ex vivo sorting data, suggest that these T cells are islet infiltrates from donors with T1D and are not from lymphocytes in islet capillaries.
Islet infiltration in individuals with T1D is heterogeneous: adjacent pancreatic lobes can differ in the presence or absence of insulitis, and infiltrated islets can exist in close proximity to noninfiltrated, normal-appearing islets 15 . In agreement with this heterogeneity, a range of 10-1,178 T cells from 100 handpicked islets was detected by flow cytometry, and we detected cellular outgrowth from an average of 26% islets plated (outgrowth from a range of 9-45 individual islets for 100 islets per sample) (Supplementary Table 1) . A meta-analysis of immunohistochemistry studies to define insulitis described islet infiltration as ≥15 CD45 + cells per islet, and insulitis as infiltration in <10% islets, although greater numbers of islet-infiltrating CD45 + lymphocytes have been detected in some nPOD sample pancreata from donors with T1D 5, 6 . Neither immunohistochemistry nor the isolation of live, islet-infiltrating T cells can measure all infiltrated T cells because sectioning and staining through entire islets or pancreas is not possible, and the use of all isolated islets from an entire pancreas for autoimmunity studies is generally not possible. Owing to the heterogeneous nature of the insulitis and the rarity of pancreatic tissue from donors with T1D, sampling might not be equivalent in any given islet preparation. On the basis of average recovery of islets from donors with T1D, we calculated that we examined 0.56% of recovered islets for T cell infiltration (Supplementary Table 3) .
Next we tested the autoreactivity of CD4 + T cell lines and clones grown and sorted from islets of donors with T1D by using peptide panels derived from islet-associated proteins known either to bind to HLA-DR3, HLA-DR4 or HLA-DQ8 and/or to elicit T cell responses from the peripheral blood of individuals with these risk alleles 1 . For each T cell line or clone, either autologous or HLA-matched Epstein-Barr virus (EBV)-transformed B cells (Figs. 2 and 3) were pulsed with peptides for 2 h and then cultured with T cell lines or clones for 48 h. Reactivity was measured by cytokine secretion, as detected by an enzyme-linked immunosorbent assay (ELISA) and or Luminex. We detected CD4 + T cell responses to glutamic acid decarboxylase 65 (GAD) GAD [555] [556] [557] [558] [559] [560] [561] [562] [563] [564] [565] [566] [567] (Fig. 2a) , proinsulin [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] ( Fig. 2b) , GAD [274] [275] [276] [277] [278] [279] [280] [281] [282] [283] [284] [285] [286] (Fig. 2c) , GAD [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] (Fig. 2d) and islet antigen (IA)-2 545-562 (Fig. 2e) .
To screen for T cell reactivity from processed whole protein, we used a panel of Priess B cells that were transduced with constructs encoding autoantigens that have been identified as targets of autoreactive T cells in T1D 1 . We detected a CD4 + T cell line grown from an islet from donor nPOD6323 that responded to Priess B cells expressing chromogranin A (Fig. 2f) , and from individual islets from donor nPOD69, two CD4 + T cell lines recognized Priess B cells expressing (pre)proinsulin (Fig. 2g,h) , and one recognized the Priess B cells expressing chromogranin A (Fig. 2i) . As compared to the parent B cells, T cell lines had positive stimulation indices to the B cells expressing autoantigen over their response to B cells alone (stimulation index (SI) = 2-4), but they were not as robust as other lines that responded to some peptides (e.g., Fig. 2b ; SI = 16.8).
Three expanded CD8β + T cell lines from donor nPOD6268 were probed for autoreactivity through the use of pooled HLA-A2 pentamers loaded with known islet peptide targets 3 . All three lines had increased numbers of CD8β + T cells bound with the pool of HLA-A2 pentamers loaded with insulin B [10] [11] [12] [13] [14] [15] [16] [17] [18] , IA-2 797-805 and islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) 265-273 peptides, as compared to the numbers of CD8 + T cells bound by the HLA-A2 mulitmer loaded with the malaria peptide ( Fig. 2j-l) . After two rounds of expansion, 99% of the CD8β + T cells in these lines were of unknown reactivity, which indicates a broader range of CD8 + autoreactivity than has been previously reported for T1D 3 .
The autoreactivity of T and B cells in autoimmune diseases with post-translationally modified peptides is a potential mechanism by which tolerance to autoantigens can be broken. T and B cell reactivity to post-translationally modified epitopes 16 has been detected in the context of rheumatoid arthritis 17 , celiac disease 18 and T1D [19] [20] [21] [22] [23] [24] [25] [26] : for example, (pre)proinsulin and IA-2 peptides in the context of the highrisk DQ8-trans class II molecule 10, 27 . In previous studies, human peripheral autoreactive T cells responded to epitopes containing posttranslational modifications such as a vicinal disulfide bond in insulin 20 , citrullination or deamidation 19, [21] [22] [23] [24] [25] [26] [27] , or islet-derived T cells with Fig. 2 ). Among the T cells studied here, a CD4 + T cell line grown from an islet from donor nPOD6323 recognized glucose-regulated protein 78 (GRP78) 292-305 with an arginine to citrulline modification at position 297 (Fig. 3a) . A CD4 + T cell clone sorted from islets from donor T1D.7 recognized IAPP 65-84 with arginine to citrulline modifications at positions 73 and 81 (Fig. 3b) . From donor nPOD6367, a CD4 + T cell line recognized the hybrid insulin-peptide fusion with an insulin-A chain peptide (Fig. 3c) . From donor nPOD6323, two CD4 + T cell lines recognized different hybrid insulin-peptide fusions of different two peptides from IAPP ( Fig. 3d,e) . Autoreactive CD4 + T cells detected here produced interferon (IFN)-γ; all lines and clones secreted different patterns of cytokines upon peptide stimulation, with some additionally secreting tumor necrosis factor (TNF-α) and/or interleukin (IL)-2 with variable secretion of IL-9, C-C motif chemokine ligand 20 (CCL20) or granulocytemacrophage colony-stimulating factor (GM-CSF). Two lines secreted IL-13 in a nonpeptide-specific manner. IL-4 and IL-5 were not detected from any autoreactive T cell line or clone ( Supplementary  Fig. 3 ). These data indicate an inflammatory islet microenvironment in donors with T1D.
Both insulin secretion, as measured by C-peptide in the circulation 29 , and islet autoimmunity, as measured by islet infiltrate 5 , persist for decades after diagnosis in many patients with T1D. Moreover, the chronic destructive function of islet autoimmunity is also observed in partial pancreas transplants between identical twins who are discordant for T1D 30 , and even in some immunosuppressed pancreastransplant recipients from unrelated donors 31 . For islet replacement or regeneration to be successful, the islet-infiltrating lymphocytic response must be understood and prevented or suppressed, ideally by using antigen-specific therapies (as opposed to general immunosuppression with its attendant toxicities).
This work defines and extends 10 our knowledge of autoreactive T cell responses in human T1D, which is needed to target isletinfiltrating T cell autoreactivity. Study of human samples is important, because therapies in rodent models of T1D have not translated well to durable clinical benefit 32, 33 . An important aspect of defining the Table 1 ) and cultured for 1-3 rounds (4-6 weeks) with irradiated allogeneic feeders, PHA-P and IL-2, IL-7 and IL-15. knowledge of the diversity of the islet infiltrating, autoreactive, proinflammatory response in human T1D is crucial for the successful design of durable autoantigen-specific tolerance induction therapies for those at risk of developing, and those with established, T1D.
MeTHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINe MeTHODS
Islet donors. We studied isolated human islets from donors with established T1D (n = 9) and from donors without a diagnosis of T1D (n = 7) or with T2D (n = 2). Table 3) . A schema of islet handling from receipt to T cell sorting and growth is shown (Fig. 1a) . Islets were received for experimental use 2-5 d after donor's brain death. We received ~500-1,000 islet equivalents per donor of variable purity (10-80%). Islets were handpicked under a dissecting microscope for increased purity. For the two methods of analysis of islet-infiltrating T cells, we assayed 200 IEQs, corresponding to an average of 0.56% of recovered IEQ examined (Supplementary Table 3 ).
Handpicking of islets under a dissecting microscope for increased purity occurred over 2-3 h. 100 handpicked islets were enzyme-dispersed, washed and stained with viability dye and lymphocyte markers (see 'Ex vivo detection and sorting of islet-infiltrating lymphocytes') (~75 min). Cells were detected and sorted within 6 h of islet receipt. Sorted cells were cultured for 12-14 d with 1-2 rounds (a total of 4-6 weeks) of stimulation (see 'Ex vivo detection and sorting of islet-infiltrating lymphocytes' below) and then characterized in the same manner as the T cell lines. All clones and lines were cryopreserved. Tallies of CD4 + and CD8 + T cells detected by ex vivo flow cytometry from dispersed islets is shown in Supplementary Table 1 and from donors without  T1D (Supplementary Table 2) . Another aliquot of 100 handpicked islets was immediately put into culture on gel-based culture with T cell stimulation and growth factors (see 'Direct growth of T cells from islets'). These islets remained in culture for 5-10 d with daily microscopic inspection. When cellular outgrowth was observed from individual islets, cells were collected by pipette under a dissecting microscope and placed in culture as individual lines with cytokine for expansion. An aliquot of each line was tested for T cell subset by flow cytometry. Tallies of the numbers of CD4, CD8, and CD4/CD8 mixed T cell lines grown from individuals plus the number of CD4 or and CD8 T cell clones sorted ex vivo from dispersed islets are shown in Supplementary Table 1 for the donors with T1D and for the donors without  T1D (Supplementary Table 2 ).
Ex vivo detection and sorting of islet-infiltrating lymphocytes. Within 4-6 h of islet receipt, 100 handpicked islets were enzymatically dispersed (TrypLE, Thermo Fisher), washed and stained with vital dye (1:100 dilution in a 100-µl volume, Zombie Violet, BioLegend) 36 , anti-CD45, anti-CD3 (BioLegend) and anti-CD19, anti-CD4 and anti-CD8 (BD BioSciences). Anti-CD3 and anti-CD45 were used at a dilution of 1:100 and anti-CD4, anti-CD8 and anti-CD19 were used at a dilution of 1:25 in a 100-µl volume. To retain all islet-infiltrating T cells, CD4 + and CD8 + T cells were sorted (BD FACSAria) onto irradiated, allogeneic peripheral blood mononuclear cells in complete media (HL-1 media, supplemented with 2 mM l-glutamine, 5 mM HEPES and 100 U/ml penicillin and 100 µg/ml streptomycin, 0.1 mM each nonessential amino acids, 1 mM sodium pyruvate (all from Lonza) and 5% heat-inactivated human male AB serum (Omega Scientific) with 4.5 µg/ml PHA-P (Thermo Scientific) for T cell stimulation plus IL-2 (20 U/ml) (Proleukin), IL-4, IL-7 and IL-15 (all at 10 ng/ml) (Peprotech), a blocking anti-Fas antibody (eBiosciences), anti-PD-1 antibody (BD Biosciences) (all antibodies at 1 µg/ml) and mifepristone (100 nM) (Invitrogen) 37 . For rounds of restimulation, T cell lines or clones were stimulated with irradiated allogeneic feeders, PHA-P, IL-2, IL-7, IL-4 and IL-15 in complete media with 5% human serum, as described above. In all figures, labeling of a clone denotes that the T cell was single-cell sorted from dispersed islets; labeling as a line denotes growth from an individual islet.
Direct growth of T cells from islets.
Immunohistochemical examination of pancreata has shown that acinar tissue can contain lymphocytes 38, 39 . Although we enriched for islets by handpicking, carryover is possible; therefore, we developed a gel-based method for visualization, growth and retrieval of cellular outgrowth from individual islets. Another 100 handpicked islets were plated on tissue culture plates (CoStar) coated with Matrigel (Corning Life Sciences) in media with growth factors described above (without PHA-P) with anti-CD3 and anti-CD28 (both at 5 µg/ml) (BD BioSciences), a blocking anti-Fas antibody (eBiosciences), anti-PD-1 antibody (BD Biosciences) (all antibodies at 1 µg/ml) and mifepristone (100 nM) for T cell stimulation. Cellular outgrowths were collected under a dissecting microscope after 5-10 d, and expanded with growth factors described (without T cell stimulation), and assayed by flow cytometry for CD4 and CD8β expression (Coulter). Both CD4 and CD8 T cell lines are considered polyclonal (e.g., Fig. 2j-l) and require cloning. In addition, 102 T cell lines grown from individual islets from six of nine islet donors with T1D were mixtures of CD4 and CD8 T cells, which require separation and cloning by fluorescence-activated cell sorting (FACS) (Supplementary Table 1 and Supplementary Fig. 1) . We have noted an isletderived CD4 + T cell growth bias over islet-derived CD8 + T cells, indicating the importance of separation of CD4 and CD8 T cells at the sorting step, or as soon as cellular outgrowth is detected from the islets, to have a fair representation of the T cell composition of the insulitis. Fig. 4 ).
Antigen-presenting cells (APCs
Peptides. Autoreactive peptides with reported reactivity to HLA-DR3, HLA-DR4 or HLA-DQ8 (ref. 1) described in the figures were synthesized by New England Peptide or Sigma-Aldrich (>95% purity). Peptides showing binding or reactivity in the context of DR17, DR4 and DQ8 were chosen from GAD65,
